Research Paper Volume 12, Issue 8 pp 7112—7128
Identification of immunologic subtype and prognosis of GBM based on TNFSF14 and immune checkpoint gene expression profiling
Figure 9. Levels of TNFSF14 expression relative to common pathology in glioma tissue. (A) Levels of expression and representative photographs of immunohistochemical staining of TNFSF14 in different grades of gliomas. (B) Quantitative bar graphs of immunohistochemical staining in each grade.